GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » e-Therapeutics PLC (LSE:ETX) » Definitions » Other Long Term Assets

e-Therapeutics (LSE:ETX) Other Long Term Assets : £-0.00 Mil (As of Jul. 2023)


View and export this data going back to 2007. Start your Free Trial

What is e-Therapeutics Other Long Term Assets?

e-Therapeutics's other long-term assets for the quarter that ended in Jul. 2023 was £-0.00 Mil.

e-Therapeutics's quarterly other long-term assets increased from Jul. 2022 (£-0.00 Mil) to Jan. 2023 (£0.00 Mil) but then stayed the same from Jan. 2023 (£0.00 Mil) to Jul. 2023 (£-0.00 Mil).

e-Therapeutics's annual other long-term assets declined from Jan. 2021 (£0.00 Mil) to Jan. 2022 (£0.00 Mil) but then increased from Jan. 2022 (£0.00 Mil) to Jan. 2023 (£0.00 Mil).


e-Therapeutics Other Long Term Assets Historical Data

The historical data trend for e-Therapeutics's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

e-Therapeutics Other Long Term Assets Chart

e-Therapeutics Annual Data
Trend Jan14 Jan15 Jan16 Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23
Other Long Term Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

e-Therapeutics Semi-Annual Data
Jan14 Jul14 Jan15 Jul15 Jan16 Jul16 Jan17 Jul17 Jan18 Jul18 Jan19 Jul19 Jan20 Jul20 Jan21 Jul21 Jan22 Jul22 Jan23 Jul23
Other Long Term Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

e-Therapeutics Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.


e-Therapeutics (LSE:ETX) Business Description

Traded in Other Exchanges
Address
4 Kingdom Street, Paddington, London, GBR, W2 6BD
e-Therapeutics PLC is a drug discovery company. Its ambition is to transform the drug discovery process, leveraging its computational network biology platform (drug discovery) to find novel targets to address mechanisms underpinning complex disease. l company activities are carried out in the UK.

e-Therapeutics (LSE:ETX) Headlines